AGL · Agilon Health, Inc.
AI read · Neutral
The AI's read
The rating repeats Wells Fargo's existing view, not a new report about Agilon's sales, costs, or care business. It gives no new company results or forecast to show that the outlook changed.
Wells Fargo kept its existing Overweight rating, but reported no new company results or forecast. The update therefore does not change what is known about Agilon's outlook.
The rating repeats Wells Fargo's existing view, not a new report about Agilon's sales, costs, or care business. It gives no new company results or forecast to show that the outlook changed.
Follow Agilon Health, Inc. (AGL) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for AGL